We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
6.00 | 3.16% | 196.00 | 195.00 | 196.00 | 197.40 | 189.20 | 190.20 | 780,056 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 124.33M | 20.41M | 0.0939 | 20.81 | 424.43M |
TIDMAMS
RNS Number : 5926F
Advanced Medical Solutions Grp PLC
18 May 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------------- 1. Identity of the issuer or Advanced Medical Solutions the underlying issuer Group plc of existing shares to which voting rights are attached: (ii) ------------------------------------------------------ ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ü ------------------------------------------------------- ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------- ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------- ----------------------------- An event changing the breakdown of voting rights ------------------------------------------------------- ----------------------------- Other (please specify): ----------------------------------------------------- ----------------------------- 3. Full name of person(s) Octopus Investments Nominees subject to the Limited notification obligation: (iii) ------------------------------------------------------ ------------------------------ 4. Full name of shareholder(s) n/a (if different from 3.):(iv) ------------------------------------------------------ ------------------------------ 5. Date of the transaction 17/05/2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------ ------------------------------ 6. Date on which issuer 18/05/2017 notified: ------------------------------------------------------ ------------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 9% ------------------------------------------------------ ------------------------------ 8. Notified details: n/a ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- --------------------------------- -------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- --------------- ---------------- -------------- ------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ------------ -------------- ----------- ------------ ------------ ----------- GB0004536594 18858157 18858157 18947547 18947547 9% --------------- ---------------- -------------- ----------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- -------------------------------- --------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- -------------- ---------------- --------------------------- ----------------------- Nominal Delta --------------- ------------- -------------- ---------------- --------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------- ------------------------------------------------------------------ 18947547 9% -------------------------------------------------- ------------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------- n/a Proxy Voting: -------------------------------------------------------------------------- 10. Name of the proxy holder: n/a ------------------------------------------------------- ----------------- 11. Number of voting rights proxy n/a holder will cease to hold: ------------------------------------------------------- ----------------- 12. Date on which proxy holder will n/a cease to hold voting rights: ------------------------------------------------------- ----------------- 13. Additional information: ------------------------------------------------------- ----------------- 14. Contact name: Annaliese Maisch ------------------------------------------------------- ----------------- 15. Contact telephone number: 020 7716 6477 ------------------------------------------------------- -----------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWUVRBOAVAAR
(END) Dow Jones Newswires
May 18, 2017 11:26 ET (15:26 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions